Familial idiopathic methemoglobinemia revisited: Original cases reveal 2 novel mutations in NADH-cytochrome b5 reductase

37Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

In 1943, the first description of familial idiopathic methemoglobinemia in the United Kingdom was reported in 2 members of one family. Five years later, Quentin Gibson (then of Queen's University, Belfast, Ireland) correctly identified the pathway involved in the reduction of methemoglobin in the family, thereby describing the first hereditary trait involving a specific enzyme deficiency. Recessive congenital methemoglobinemia (RCM) is caused by a deficiency of reduced nicotin-amide adenine dinucleotide (NADH)-cytochrome b5 reductase. One of the original propositi with the type 1 disorder has now been traced. He was found to be a compound heterozygote harboring 2 previously undescribed mutations in exon 9, a point mutation Gly873Ala predicting a Gly291Asp substitution, and a 3-bp inframe deletion of codon 255 (GAG), predicting loss of glutamic acid. A brother and a surviving sister are heterozygous; each bears one of the mutations. Thirty-three different mutations have now been recorded for RCM. The original authors' optimism that RCM would provide material for future genetic studies has been amply justified. © 2002 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Percy, M. J., Gillespie, M. J. S., Savage, G., Hughes, A. E., McMullin, M. F., & Lappin, T. R. J. (2002). Familial idiopathic methemoglobinemia revisited: Original cases reveal 2 novel mutations in NADH-cytochrome b5 reductase. Blood, 100(10), 3447–3449. https://doi.org/10.1182/blood-2002-05-1405

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free